Roche Holding AG to Discuss Key Hematology Data Presented at ASH 2019 Transcript
Ladies and gentlemen, welcome to the Roche Analyst Audio Webcast and Conference Call for ASH 2019. I am Sandra, the Chorus Call operator. (Operator Instructions) The conference is being recorded. The presentation will be followed by a Q&A session. (Operator Instructions) Webcast viewers may submit their questions in writing via the relative field. (Operator Instructions) The conference must not be recorded for publication or broadcast.
At this time, it's my pleasure to hand over to Karl Mahler, Head of Investor Relations. Please go ahead, sir.
Yes, thanks a lot. Welcome to everybody. Good morning, good evening. Thanks that you found the time to participate in our call and, of course, of this year's ASH. And I've also trusted you with an opportunity either to download the presentation from the web or to follow us on the web.
I'm here today with Tom Fuchs. He is the Vice President of the Hematology Franchise from the commercial part, the GPS part. And we are also joined by Nancy Valente. He is the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
